Scarica l'app Stockscreener
2.12
8.72%
0.17
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BMEA Giù?
Forum
Previsione
Biomea Fusion Inc Borsa (BMEA) Ultime notizie
Biomea Fusion stock hits 52-week low at $1.86 amid sharp decline - Investing.com Australia
Biomea Fusion stock hits 52-week low at $1.86 amid sharp decline By Investing.com - Investing.com South Africa
HC Wainwright Reduces Earnings Estimates for Biomea Fusion - Defense World
Barclays Issues Pessimistic Forecast for Biomea Fusion (NASDAQ:BMEA) Stock Price - Defense World
HC Wainwright Weighs in on Biomea Fusion Q1 Earnings - Defense World
After Plunging -27.9% in 4 Weeks, Here's Why the Trend Might Reverse for Biomea Fusion (BMEA) - Yahoo Finance
Biomea Fusion’s Strategic Shift: A Year of Transformation - TipRanks
Biomea Fusion, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - MarketScreener
Biomea Fusion, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Biomea Fusion Expands Team with Strategic Equity Compensation Package - Stock Titan
After Plunging -19.32% in 4 Weeks, Here's Why the Trend Might Reverse for Biomea Fusion (BMEA) - Yahoo Finance
Biomea Fusion Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Biomea Fusion (NASDAQ:BMEA) Receives “Buy” Rating from HC Wainwright - Defense World
Biomea Fusion reports Q4 EPS (81c), consensus (93c) - TipRanks
Biomea Fusion, Inc. SEC 10-K Report - TradingView
Biomea Fusion Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Highlights - The Manila Times
Breakthrough: Biomea's Diabetes Treatment Achieves Major Blood Sugar Control Milestone - Stock Titan
After Plunging -20.42% in 4 Weeks, Here's Why the Trend Might Reverse for Biomea Fusion (BMEA) - Yahoo Finance
Virtu Financial LLC Makes New Investment in Biomea Fusion, Inc. (NASDAQ:BMEA) - Defense World
Biomea Fusion, Inc. (NASDAQ:BMEA) Shares Sold by Charles Schwab Investment Management Inc. - Defense World
Biomea Fusion (BMEA) to Release Earnings on Monday - Defense World
BIOMEA FUSION Earnings Preview: Recent $BMEA Insider Trading, Hedge Fund Activity, and More - Nasdaq
Biomea Fusion Inc expected to post a loss of 92 cents a shareEarnings Preview - TradingView
Biomea Fusion stock hits 52-week low at $2.33 amid sharp decline By Investing.com - Investing.com South Africa
Biomea Fusion stock hits 52-week low at $2.33 amid sharp decline - Investing.com Australia
Biomea Fusion, Inc. (NASDAQ:BMEA) Given Average Rating of “Buy” by Brokerages - Defense World
Thomas Butler steps down as Biomea CEO - biocentury.com
Biomea Fusion Appoints Michael Hitchcock Interim CEO - MarketScreener
Biomea Fusion appoints Mick Hitchcock to succeed Thomas Butler as interim CEO - Seeking Alpha
Biomea Fusion’s SWOT analysis: stock’s potential amid clinical trials By Investing.com - Investing.com Australia
Biomea Fusion names Mick Hitchcock to succeed Thomas Butler as interim CEO - TipRanks
Biomea Fusion Announces Leadership Transition - GlobeNewswire
Former Gilead Sciences VP Named CEO as Biomea Advances Breakthrough Diabetes Drug - Stock Titan
Strategy (MSTR) Executives Buy Company’s Preferred Stock - The Globe and Mail
Stocks in play: Trilogy Metals Inc. - The Globe and Mail
Biomea Fusion’s SWOT analysis: stock’s potential amid clinical trials - Investing.com India
Biomea Fusion announces presentation of icovamenib preclinical, clinical data - Yahoo Finance
Biomea Fusion (NASDAQ:BMEA) Given Buy Rating at HC Wainwright - Defense World
Biomea Fusion Presents Promising Clinical Data on Icovamenib at ATTD 2025, Highlighting Its Potential as a Disease-Modifying Therapy for Type 2 Diabetes - Nasdaq
Icovamenib Treatment in Patients with Severe - GlobeNewswire
Icovamenib Treatment in Patients with Severe Insulin-Deficient Diabetes Led to a Significant Improvement in Pancreatic Beta-cell Function with a 53% Mean Increase in C-peptide Levels 3 Months After Last Dose - Yahoo Finance
Investors who Lost Money on Biomea Fusion, Inc. Should Contact Levi & Korsinsky About an Ongoing InvestigationBMEA - ACCESS Newswire
Biomea Fusion Insiders Recover Some Losses, Which Stand At US$91k - Yahoo
D. Boral Capital Reiterates “Buy” Rating for Biomea Fusion (NASDAQ:BMEA) - Defense World
Biomea Fusion stock hits 52-week low at $2.49 amid sharp decline - Investing.com
Levi & Korsinsky Investigates Possible Securities Fraud Violations by Biomea Fusion, Inc. (BMEA) - accessnewswire.com
Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Biomea Fusion reports inducement grant under Nasdaq listing rule - TipRanks
How Biomea Fusion's Latest Employee Stock Grant Reflects Its Talent Acquisition Strategy - StockTitan
An Investigation Has Commenced on Behalf of Biomea Fusion, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your BMEA Losses - ACCESS Newswire
Biomea Fusion, Inc. (NASDAQ:BMEA) Receives Consensus Rating of “Buy” from Analysts - Defense World
Biomea Fusion CFO Franco Valle Resigns - TipRanks
3.01%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):